Effect of 1-O-ethyl-3-butylcyclohexanol on the skin permeation of drugs with different physicochemical characteristics

International Journal of Pharmaceutics

Volumn 259, Issue 1-2, 2003, Pages 193-198

  Li, Chao Jie ^a   Obata, Yasuko ^a   Higashiyama, Kimio ^a   Nagai, Tsuneji ^a   Takayama, Kozo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

1 O ethyl 3 butylcyclohexanol; Absorption enhancer; Lipophilicity; Molecular weight; Multiple regression analysis; Physicochemical properties; Skin permeation

Indexed keywords

1 O ETHYL 3 BUTYLCYCLOHEXANOL; ALCOHOL; AMINOPHENAZONE; CARBOMER; CYCLOHEXANOL DERIVATIVE; DRUG ADDITIVE; FLURBIPROFEN; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; KETOPROFEN; OCTANOL; PENTOXIFYLLINE; PHENAZONE; SALICYLIC ACID; TRIAMCINOLONE; TRIETHANOLAMINE; UNCLASSIFIED DRUG; WATER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG DIFFUSION; DRUG EFFECT; DRUG PENETRATION; EVALUATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEL; LIPOPHILICITY; MALE; MOLECULAR WEIGHT; MULTIPLE REGRESSION; NONHUMAN; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SKIN PENETRATION;

EID: 0038699624     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00210-2     Document Type: Article

References (14)

1. Cronin M.T.D., Dearden J.C., Moss G.P., Murray-Dickson G. Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships. Eur. J. Pharm. Sci. 7:1999;325-330.
2. Ghanem A.H., Mahmoud H., Higuchi W.I., Liu P., Good W.R. The effect of ethanol on the transport of lipophilic and polar permeants across hairless mouse skin: methods/validation of a novel approach. Int. J. Pharm. 78:1992;137-156.
3. Hatanaka T., Inuma M., Sugibayashi K., Morimoto Y. Prediction of skin permeability of drugs. I. Comparison with artificial membrane. Chem. Pharm. Bull. 38:1990;3452-3459.
4. Lee C.K., Uchida T., Kitagawa K., Yagi A., Kim N.S., Goto S. Skin permeability of various drugs with different lipophilicity. J. Pharm. Sci. 83:1994;562-565.
5. Li C.J., Higashiyama K., Yoshimura Y., Nagai T., Takayama K., Obata Y. Promoting mechanism of menthol derivative 1-O-ethyl-3-buthylcyclohexanol on the percutaneous absorption of ketoprofen. Biol. Pharm. Bull. 24(9):2001;1044-1048.
6. Moss G.P., Cronin M.T.D. Quantitative structure-permeability relationships for percutaneous absorption: re-analysis of steroid data. Int. J. Pharm. 238:2002;105-109.
7. Negishi J., Takayama K., Higashiyama K., Chiba Y., Isowa K., Nagai T. Promoting effect of O-alkylmenthol and O-acylmenthol derivatives on the percutaneous absorption of ketoprofen in rats. S.T.P. Pharm. Sci. 5:1995;156-161.
8. Obata Y., Sato H., Li C.J., Takayama K., Higashiyama K., Nagai T., Isowa K. Effect of synthesized cyclohexanol derivatives using L-menthol as a lead compound on the percutaneous absorption of ketoprofen. Int. J. Pharm. 198:2000;191-200.
9. Obata Y., Takayama K., Maitani Y., Machida Y., Nagai T. Effect of pretreatment of skin with cyclic monoterpenes on permeation of diclofenac in hairless rat. Biol. Pharm. Bull. 16:1993;312-314.
10. Obata Y., Li C.J., Fujikawa M., Takayama K., Sato H., Higashiyama K., Isowa K., Nagai T. Evaluation and structure-activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen using artificial neural network. Int. J. Pharm. 212:2001;223-321.
11. Okamoto H., Yamashita F., Saito K., Hashida M. Analysis of drug penetration through the skin by the two-layer skin model. Pharm. Res. 11:1989;931-937.
12. Phillips C.A., Michiniak B.B. Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhancers. J. Pharm. Sci. 84:1995;1427-1433.
13. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 9:1992;663-669.
14. Wu P.C., Obata Y., Fujikawa M., Li C.J., Higashiyama K., Takayama K. Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancer. J. Pharm. Sci. 90:2001;1004-1014.